Molecular profiling of stroma identifies osteopontin as an independent predictor of poor prognosis in intrahepatic cholangiocarcinoma
Laurent Sulpice(Inserm), Cédric Coulouarn(Inserm), Bruno Clément(Inserm), Éveline Boucher(Boston Scientific (United States)), Bruno Turlin(Inserm), Michel Rayar(Hôpital Pontchaillou), B. Meunier(Hôpital l'Archet), Francisco Llamas‐Gutierrez(Centre Hospitalier Universitaire de Rennes), Alain Fautrel, Mireille Desille(Inserm), Karim Boudjéma(Inserm)
Cited by 147
Related Papers
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
A New Mouse Liver-specific Gene, Encoding a Protein Homologous to Human Antimicrobial Peptide Hepcidin, Is Overexpressed during Iron Overload
|Journal of Biological Chemistry|2001|1.7k
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
|Journal of Clinical Oncology|2013|775